Sidra Mahmood

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

Luc Friboulet, Nanxin Li, Ryohei Katayama et al. · Cancer Discovery · 2014 · 820 citations · Full text

PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models

Helen Y. Zou, Luc Friboulet, David P. Kodack et al. · Cancer Cell · 2015 · 456 citations · Full text

Drug Target, Health Sciences, Preclinical Models +10

Acquired Resistance to Crizotinib from a Mutation in <i>CD74</i>–<i>ROS1</i>

Mark M. Awad, Ryohei Katayama, Michele McTigue et al. · New England Journal of Medicine · 2013 · 408 citations · Full text

Genome Instability, Same Resistance Mutation, Oncogenic Agent +14

Combined targeting of HER2 and VEGFR2 for effective treatment of<i>HER2</i>-amplified breast cancer brain metastases

David P. Kodack, Euiheon Chung, Hiroshi Yamashita et al. · Proceedings of the National Academy of Sciences · 2012 · 152 citations · Full text

On electroosmosis in peristaltic activity of MHD non-Newtonian fluid

Anum Tanveer, Sidra Mahmood, Tasawar Hayat et al. · Alexandria Engineering Journal · 2021 · 68 citations · Full text

Third Grade Fluid, Engineering, Electrohydrodynamics +14